BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma
BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma
About this item
Full title
Author / Creator
Publisher
New York: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Synovial sarcoma (SS) is an aggressive tumor that most often affects the deep soft tissues in young adults. Intrathoracic SS is rare and is associated with poor outcome, highlighting the urgent need for a novel therapeutic strategy. In the process of clinical sequencing, we identified two patients with intrathoracic SS harboring the BRAF V600E muta...
Alternative Titles
Full title
BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2385709551
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2385709551
Other Identifiers
ISSN
0893-3952
E-ISSN
1530-0285
DOI
10.1038/s41379-020-0530-3
